From: Expression characteristics and their functional role of IGFBP gene family in pan-cancer
Cluster | Keywords | Counts | Rank | Cluster | Keywords | Counts | Rank |
---|---|---|---|---|---|---|---|
1 | expression | 758 | 1 | 2 | risk | 356 | 7 |
1 | cancer | 434 | 2 | 2 | factor (igf)-i | 261 | 10 |
1 | gene-expression | 245 | 11 | 2 | insulin | 216 | 14 |
1 | cells | 235 | 12 | 2 | colorectal-cancer | 190 | 18 |
1 | growth | 194 | 17 | 2 | igfbp-3 | 174 | 22 |
1 | proliferation | 185 | 19 | 2 | binding protein-3 | 162 | 25 |
1 | carcinoma | 172 | 23 | 2 | serum | 141 | 29 |
1 | gene | 164 | 24 | 2 | igf-binding protein-3 | 133 | 31 |
1 | activation | 155 | 26 | 2 | hormone | 128 | 33 |
1 | messenger-rna | 153 | 27 | 2 | plasma-levels | 128 | 35 |
1 | progression | 138 | 30 | 2 | serum-levels | 110 | 36 |
1 | survival | 130 | 32 | 2 | association | 102 | 38 |
1 | identification | 128 | 34 | 2 | postmenopausal women | 97 | 40 |
1 | pathway | 100 | 39 | 2 | women | 97 | 41 |
1 | lung-cancer | 90 | 43 | 2 | circulating levels | 95 | 42 |
1 | metastasis | 89 | 44 | 2 | factor system | 83 | 49 |
1 | differentiation | 88 | 45 | 2 | men | 79 | 52 |
1 | resistance | 88 | 46 | 2 | system | 75 | 53 |
1 | invasion | 86 | 47 | 2 | cancer risk | 70 | 56 |
1 | binding | 85 | 48 | 2 | colon-cancer | 67 | 59 |
1 | cancer cells | 81 | 50 | 2 | body-mass index | 66 | 60 |
1 | igf-ii | 79 | 51 | 2 | c-peptide | 65 | 61 |
1 | overexpression | 74 | 54 | 2 | disease | 64 | 62 |
1 | protein | 71 | 55 | 2 | physical-activity | 64 | 64 |
1 | phosphorylation | 64 | 63 | 2 | breast-cancer risk | 61 | 66 |
1 | down-regulation | 60 | 68 | 2 | factor-binding-proteins | 58 | 72 |
1 | kinase | 60 | 69 | 2 | prostate-cancer risk | 58 | 73 |
1 | therapy | 60 | 70 | 2 | i igf-i | 57 | 75 |
1 | in-vitro | 59 | 71 | 2 | cancer-risk | 56 | 76 |
1 | cancer-cells | 57 | 74 | 2 | obesity | 54 | 79 |
1 | cell-proliferation | 56 | 77 | 2 | factor binding-protein-3 | 52 | 81 |
1 | adenocarcinoma | 54 | 78 | 2 | estrogen | 50 | 83 |
1 | marker | 53 | 80 | 2 | antigen | 47 | 88 |
1 | growth-factor | 52 | 82 | 2 | insulin-like-growth-factor-1 | 43 | 95 |
1 | angiogenesis | 49 | 84 | 3 | receptor | 266 | 8 |
1 | migration | 49 | 86 | 3 | apoptosis | 261 | 9 |
1 | prognosis | 48 | 87 | 3 | prostate-cancer | 220 | 13 |
1 | family | 45 | 91 | 3 | factor-binding protein-3 | 215 | 15 |
1 | tumors | 45 | 92 | 3 | breast-cancer cells | 197 | 16 |
1 | mechanisms | 44 | 94 | 3 | binding-proteins | 182 | 20 |
1 | proteins | 43 | 96 | 3 | inhibition | 175 | 21 |
1 | tumor | 43 | 97 | 3 | factor-i receptor | 142 | 28 |
1 | domain | 41 | 98 | 3 | epithelial-cells | 108 | 37 |
1 | growth-factor-ii | 41 | 99 | 3 | factor receptor | 68 | 57 |
1 | poor-prognosis | 41 | 100 | 3 | tumor-growth | 68 | 58 |
1 | transcription | 41 | 101 | 3 | transgenic mice | 63 | 65 |
1 | hepatocellular-carcinoma | 40 | 103 | 3 | signaling pathways | 61 | 67 |
1 | p53 | 40 | 104 | 3 | fibroblasts | 49 | 85 |
2 | growth-factor-i | 425 | 3 | 3 | induction | 46 | 89 |
2 | igf-i | 410 | 4 | 3 | death | 45 | 90 |
2 | factor-i | 397 | 5 | 3 | cell-lines | 44 | 93 |
2 | breast-cancer | 370 | 6 | 3 | carcinoma cells | 40 | 102 |